PharmaShots | Incisive News in 3 Shots

Subscribe Now

EU

Argenx’s Vyvgart Receives the EC’s Approval for the Treatment of Generalized Myasthenia Gravis

Argenx’s Vyvgart Receives the EC’s Approval for the Treatment of Generalized Myasthenia Gravis

August 12, 2022

Top Performing Drug of 2021 - Eliquis (July Edition)

Top Performing Drug of 2021 - Eliquis (July Edition)

July 28, 2022

Daiichi Sankyo and AstraZeneca’s Enhertu (trastuzumab deruxtecan) Receive EU Approval for HER2 Positive Metastatic Breast Cancer

Daiichi Sankyo and AstraZeneca’s Enhertu (trastuzumab deruxtecan) Receive EU Approval for HER2 Positive Metastatic Breast Cancer

July 19, 2022

GBT Reports Initiation of the P-II/III Study of GBT601 for the Treatment of Sickle Cell Disease

GBT Reports Initiation of the P-II/III Study of GBT601 for the Treatment of Sickle Cell Disease

June 30, 2022

NewAmsterdam Entered into an Exclusive License Agreement with Menarini Group to Commercialize Obicetrapib for Cardiovascular Diseases in EU

NewAmsterdam Entered into an Exclusive License Agreement with Menarini Group to Commercialize Obicetrapib for Cardiovascular Disea...

June 29, 2022

The EMA and HMA Acquired Big Data Strategy to Folster Veterinary Therapies in the EU

The EMA and HMA Acquired Big Data Strategy to Folster Veterinary Therapies in the EU

June 15, 2022

Contact Us

First Floor, B 150, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us